Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor

Nicolas Sluis-Cremer1, N Alpay Temiz, Ivet Bahar

  • 1University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania 15261, USA. CremerN@msx.dept-med.pitt.edu

Current HIV Research
|November 17, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AP2B1, a protein involved in endocytic trafficking, is associated with congenital heart defects when mutated.

Genes & diseases·2026
Same author

DruGUI 2.0: mapping protein druggability with probe-based molecular dynamics.

Bioinformatics (Oxford, England)·2026
Same author

Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cells.

Frontiers in immunology·2026
Same author

15-LOX-catalytic bias towards ether-(alkenyl)-ETE-PEs oxidation bestows selectivity of PRO-ferroptotic cell death signaling.

Nature communications·2026
Same author

Structural and molecular determinants of glutamate transporter allosteric modulators.

Molecular pharmacology·2026
Same author

Small Molecule Activators of Protein Phosphatase 2A Exert Global Stabilizing Effects on the Scaffold PR65.

JACS Au·2026

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) disrupt HIV-1 reverse transcriptase (RT) by binding to a specific pocket. This binding causes structural changes in RT, inhibiting HIV-1 replication.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Virology

Background:

  • Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are crucial in managing HIV-1 infection.
  • These drugs target the HIV-1 reverse transcriptase (RT) enzyme, a key component in viral replication.
  • NNRTIs are characterized by their diverse chemical structures and hydrophobic nature.

Purpose of the Study:

  • To review the structural, computational, and experimental evidence of NNRTI-induced conformational changes in HIV-1 RT.
  • To elucidate the mechanism by which NNRTIs inhibit HIV-1 reverse transcription.

Main Methods:

  • Structural analysis of HIV-1 RT in complex with NNRTIs.
  • Computational modeling to understand binding interactions and conformational changes.

Related Experiment Videos

  • Experimental assays to validate structural findings and functional inhibition.

    • Main Results:

    • NNRTIs bind to a specific pocket (NNRTI-binding pocket) on the p66 subunit of the HIV-1 RT p66/p51 heterodimer.
    • NNRTI binding induces both short-range and long-range structural distortions in the RT enzyme.
    • These conformational changes are directly linked to the inhibition of reverse transcription.

    Conclusions:

    • The binding of NNRTIs to HIV-1 RT triggers significant conformational alterations.
    • Understanding these structural changes provides insights into the mechanism of NNRTI-mediated inhibition of HIV-1 replication.
    • This knowledge is vital for the development of more effective antiretroviral therapies.